Inhibition of insulin-like growth factor type I (IGF-I) gene in A549 human lung cancer cell line enhances cell apoptosis and causes phenotype changes relevant to increased tumor susceptibility to immune system Source: Eur Respir J 2007; 30: Suppl. 51, 715s Year: 2007
Specific plasmids encoding shRNA molecules directed against growth factor receptors in cell proliferation inhibition and induction phenotype changes relevant to enhancement of anti-tumor immunity. Model of human non-small (NSCLC) and small (SCLC) cell lung cancer lines Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity Source: Annual Congress 2008 - Biology in thoracic tumours Year: 2008
Inhibitory effects of shRNA targeting twist on epithelial-mesenchymal transition and invasion ability of human lung carcinoma cell A549 in vitro Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006
Inhibitory effects of shRNA targeting layilin on adhesion and invasion behavior of human lung carcinoma cell A549 induced by hyaluronan in vitro Source: Eur Respir J 2006; 28: Suppl. 50, 855s Year: 2006
Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells Source: Eur Respir J 2006; 28: Suppl. 50, 325s Year: 2006
Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 Source: Annual Congress 2010 - New insights in the pathology of lung cancer Year: 2010
Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines Source: Eur Respir J 2004; 24: Suppl. 48, 5s Year: 2004
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
The expression inhibition of hnRNP-A2B1 in lung cell line A549 by small interference RNA Source: Eur Respir J 2007; 30: Suppl. 51, 144s Year: 2007
Targeting gene of insulin-like growth factor type I (IGF-I) on in vitro model of A549 cell line with triple-helix approach. Perspectives of gene therapy in non-small cell lung (NSCLC) cancer Source: Eur Respir J 2006; 28: Suppl. 50, 387s Year: 2006
MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2 Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010
Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Inhibition of the effect of epidermal growth factor (EGF) on lung cancer cells. The use of plasmids encoding specific siRNA molecules Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
The effect of siRNA on invasion capability of small cell lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012
Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
A549 cell promotes the proliferation and migration of fibroblast through FXR pathway Source: International Congress 2019 – Biology of lung cancer Year: 2019
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice Source: Eur Respir J 2002; 20: Suppl. 38, 186s Year: 2002